Radioimaging applications of and novel formulations of teboroxime
US8610075B2 · kind B2 · utility
10Cited by
556References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2007 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Feb 26, 2028 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01T1/164
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for cardiac imaging is provided, including administering to an adult human subject an amount of a teboroxime species having a radioactivity of less than 5 mCi at a time of administration, and performing a SPECT imaging procedure of a cardiac region of interest (ROI) of the subject. Other embodiments are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.